Zobrazeno 1 - 10
of 90
pro vyhledávání: '"S. Lettis"'
Publikováno v:
Alimentary Pharmacology & Therapeutics. 7:515-521
The aim of this study was to investigate the protective action of a new compound, ranitidine bismuth citrate, in the prevention of aspirin-induced acute mucosal injury to the upper gastrointestinal tract of healthy human volunteers. In a double-blind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0d17a161ab5cf9a446fabc83e2c6c81
https://doi.org/10.1111/j.1365-2036.1993.tb00127.x
https://doi.org/10.1111/j.1365-2036.1993.tb00127.x
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Diabetic Medicine. 15:772-779
The management of Type 2 diabetes mellitus with currently available oral agents may be complicated in the elderly by an increased frequency of side-effects. The effects of troglitazone, an insulin action enhancer, were studied in elderly patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f5bbfcfd3bbb24109fbea8e8c3134e3
https://doi.org/10.1002/(sici)1096-9136(199809)15:9<772::aid-dia677>3.0.co
https://doi.org/10.1002/(sici)1096-9136(199809)15:9<772::aid-dia677>3.0.co
Publikováno v:
British Journal of Clinical Pharmacology. 45:37-40
Troglitazone is an orally active anti-diabetic agent. Cholestyramine is an orally administered lipid-lowering agent which acts by binding to bile acids and removing them from enterohepatic circulation. Preclinical studies suggesting the potential for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fa78a8d57ead11c610e768d36d5577c
https://doi.org/10.1046/j.1365-2125.1998.00645.x
https://doi.org/10.1046/j.1365-2125.1998.00645.x
Autor:
D. Halliday, C. E. Robinson, S. Lettis, D. J. A. Eckland, Roman Hovorka, A. Bye, P. Bannister, M. A. Young
Publikováno v:
Scopus-Elsevier
We have investigated the reproducibility of fasting hepatic glucose output (HGO) estimates by use of isotope dilution methodology of stable-label tracers. Six normal subjects were studied on two occasions 1 wk apart. After an overnight fast, the subj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9f9d5424808837b7d39cb4e806d8ecd
https://doi.org/10.1152/ajpendo.1997.273.1.e192
https://doi.org/10.1152/ajpendo.1997.273.1.e192
Autor:
A. J. M. Boulton, S. Donoghue, F. Berthezene, Henning Beck-Nielsen, Michele Muggeo, Giatgen A. Spinas, Sudhesh Kumar, B. Persson, S. Lettis, P. Stewart-Long
Publikováno v:
Scopus-Elsevier
The effects of troglitazone, a novel thiazolidinedione, in non-insulin-dependent diabetic (NIDDM) patients were studied in a double-blind, parallel-group, placebo-controlled, dose-ranging trial. A total of 330 patients (63% male), mean age 57 years (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83bfdd3c8a2defc97d632f2e8099e790
https://doi.org/10.1007/bf00418542
https://doi.org/10.1007/bf00418542
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of clinical pharmacology. 38(9)
Troglitazone, a PPAR-gamma agonist, enhances the actions of insulin on muscle and liver. It is metabolized predominantly in the liver to a sulfate conjugate and a quinone metabolite. Acetaminophen also undergoes metabolism by conjugation. This three-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7f61a6dce05a207ae985e0644526e9c4
https://pubmed.ncbi.nlm.nih.gov/9753210
https://pubmed.ncbi.nlm.nih.gov/9753210
Publikováno v:
Diabetic medicine : a journal of the British Diabetic Association. 15(9)
The management of Type 2 diabetes mellitus with currently available oral agents may be complicated in the elderly by an increased frequency of side-effects. The effects of troglitazone, an insulin action enhancer, were studied in elderly patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7574a7817c4d91fee220c35e54705584
https://pubmed.ncbi.nlm.nih.gov/9737807
https://pubmed.ncbi.nlm.nih.gov/9737807